体内
医学微生物学
生物
肺泡巨噬细胞
微生物学
病毒学
巨噬细胞
体外
生物技术
生物化学
作者
Ying Wei,Chuangchao Zou,Siying Zeng,Ouyang Peng,Guangli Hu,Yihui Huang,Qiuping Xu,Fangyu Hu,Yongchang Cao,Hao Zhang
标识
DOI:10.1016/j.virs.2025.03.002
摘要
Porcine reproductive and respiratory syndrome (PRRS), a highly infectious immunosuppressive disease caused by porcine reproductive and respiratory syndrome virus (PRRSV), has led to significant economic losses in the global swine industry. The complexity of preventing and controlling PRRS, compounded by the limited efficacy of current vaccines, underscores the urgent need to identify antiviral targets and develop effective therapeutics against PRRSV. From the perspective of virus-host interactions, the discovery of target molecules associated with PRRSV resistance offers a promising strategy for future disease management. In this study, we conduct a comprehensive proteomic analysis using data-independent acquisition (DIA) mode to investigate the host response throughout the acute phase of PRRSV infection. This approach provides critical insights into the regulation of host antiviral and immune pathways during acute infection, advancing our theoretical understanding of PRRSV-host interactions and host gene dynamics during this critical phase. Notably, we identified SCARB2, a major lysosomal membrane protein associated with cholesterol metabolism, as a potential regulator of PRRSV replication. These findings offer novel perspectives for the prevention and control of PRRSV, contributing to the development of targeted antiviral strategies. • Proteomic profiling is performed to characterize the persistent stage of acute PRRSV infection in animal models. • PRRSV persistence dynamically modulates host antiviral mechanisms and immune signaling pathways. • Comparative analyses show substantial discrepancy between in vivo animal models and in vitro cell line proteomic datasets. • PRRSV induces sustained reduction in host MHC-associated protein levels. • SCARB2 is a potential host antiviral molecule against PRRSV infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI